Pages that link to "Q84443629"
Jump to navigation
Jump to search
The following pages link to Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond (Q84443629):
Displaying 50 items.
- The role of inflammation in schizophrenia (Q26779719) (← links)
- Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases (Q27024102) (← links)
- Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications (Q28066646) (← links)
- Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study (Q28600936) (← links)
- Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization (Q30236016) (← links)
- Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice (Q30418233) (← links)
- Inflammation and the two-hit hypothesis of schizophrenia (Q30422062) (← links)
- Viral infection, inflammation and schizophrenia (Q30440507) (← links)
- Evidence for an immune role on cognition in schizophrenia: a systematic review (Q33621692) (← links)
- Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor (Q33740560) (← links)
- Psychoneuroimmunoendocrinology: clinical implications (Q33768232) (← links)
- Antigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia (Q33809544) (← links)
- Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis (Q34035137) (← links)
- The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis (Q34047983) (← links)
- A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation (Q34405264) (← links)
- Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress. (Q35179057) (← links)
- Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation (Q35192822) (← links)
- Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study (Q35203663) (← links)
- Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms (Q35798084) (← links)
- The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis (Q35955612) (← links)
- Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat. (Q36133711) (← links)
- Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation (Q36219281) (← links)
- Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia (Q36281530) (← links)
- Simvastatin augmentation for recent-onset psychotic disorder: A study protocol (Q36324327) (← links)
- Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning. (Q36324678) (← links)
- Neural circuitry and immunity (Q36551920) (← links)
- Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression (Q36889327) (← links)
- The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders (Q37057724) (← links)
- Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives. (Q37154797) (← links)
- Peripheral endocannabinoid system dysregulation in first-episode psychosis (Q37309718) (← links)
- Cryoglobulins as potential triggers of inflammation in schizophrenia (Q37423045) (← links)
- Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia (Q37598239) (← links)
- DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders (Q37998459) (← links)
- Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA. (Q38730353) (← links)
- The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia (Q38877141) (← links)
- Cognition and psychopathology in first-episode psychosis: are they related to inflammation? (Q38884449) (← links)
- Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA. (Q39409090) (← links)
- Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model (Q40320924) (← links)
- Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia (Q40369760) (← links)
- Hippocampal volume and depressive symptoms are linked to serum IL-18 in schizophrenia. (Q40512883) (← links)
- Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations (Q41611297) (← links)
- Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation (Q42479815) (← links)
- The search for new biomarkers for cognition in schizophrenia (Q43376611) (← links)
- The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option (Q47107960) (← links)
- Immunoinflammatory Therapies in Psychiatry: Current Evidence Base (Q47137430) (← links)
- Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry. (Q47331971) (← links)
- Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review. (Q47553108) (← links)
- Schizophrenia symptomatic associations with diffusion tensor imaging measured fractional anisotropy of brain: a meta-analysis. (Q52093539) (← links)
- Molecular and Functional Neuroscience in Immunity. (Q52574293) (← links)
- Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms. (Q52645449) (← links)